Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
PROKIDNEY CORP. shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year 2026 at the 2026-05-28 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-05-28
Exact text from the filing
The appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified based on the following results of the voting: For Against Abstain Broker Non Votes 239,091,167 729,165 382,882 –
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
PROKIDNEY CORP. shareholders approved Election of three director nominees to serve for three-year terms at the 2026-05-28 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-05-28
Exact text from the filing
Based on the following results of the voting, the Company’s stockholders elected the nominees listed below to the Company’s Board of Directors, each to serve for a three-year term to expire at the Company’s annual meeting of stockholders in 2029 and until their successors are duly elected and qualified: Director Nominee For Withhold Broker Non Votes William F. Doyle 196,164,585 1,459,235 42,579,394 Alan M. Lotvin, M.D. 193,179,768 4,444,052 42,579,394 Brian J.G. Pereira 197,002,580 621,240 42,579,394
View on SEC.gov